Predictors of survival in patients with Parkinson disease

Archives of Neurology

Volumn 69, Issue 5, 2012, Pages 601-607

  Willis, Allison W ^a   Schootman, Mario ^a   Kung, Nathan ^a   Evanoff, Bradley A ^a   Perlmutter, Joel S ^a   Racette, Brad A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HISPANIC; HOSPITALIZATION; HUMAN; INFECTION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PARKINSON DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; RURAL AREA; SEX; SURVIVAL RATE; TERMINALLY ILL PATIENT; UNITED STATES; URBAN AREA;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE EXPECTANCY; MALE; PARKINSON DISEASE; POPULATION DENSITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84860905921     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.2370     Document Type: Article

References (33)

1. Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord. 2006;21(7):1002-1007. (Pubitemid 44184603)
2. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology. 2008;70(16 pt 2):1423-1430.
3. Hely MA, Morris JG, Traficante R, Reid WG, O'Sullivan DJ, Williamson PM. The Sydney Multicentre Study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry. 1999;67(3):300-307.
4. Diem-Zangerl A, Seppi K, Oberaigner W, Poewe W. Mortality in Parkinson's disease, a 20-year follow-up study. Mov Disord. 2010;25(5):661-662.
5. Marras C, McDermott MP, Rochon PA, et al Parkinson Study Group. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology. 2005;64(1):87-93. (Pubitemid 40082942)
6. Ben-Shlomo Y, Marmot MG. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry. 1995;58(3):293-299.
7. Berger K, Breteler MM, Helmer C, et al Neurologic Diseases in the Elderly Research Group. Prognosis with Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology. 2000;54(11)(suppl 5):s24-s27. (Pubitemid 30390602)
8. D'Amelio M, Ragonese P, Morgante L, et al. Long-term survival of Parkinson's disease: a population-based study. J Neurol. 2006;253(1):33-37. (Pubitemid 43157385)
9. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granérus AK. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Mov Disord. 2003;18(11):1312-1316. (Pubitemid 38263316)
10. Herlofson K, Lie SA, Arsland D, Larsen JP. Mortality and Parkinson disease: a community based study. Neurology. 2004;62(6):937-942. (Pubitemid 38435782)
11. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand. 2004; 110(2):118-123. (Pubitemid 39044049)
12. Montastruc JL, Desboeuf K, Lapeyre-Mestre M, Senard JM, Rascol O, Brefel-Courbon C. Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease. Mov Disord. 2001; 16(3):511-514. (Pubitemid 36041157)
13. Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Parkinsonism in Ontario: increased mortality compared with controls in a large cohort study. Neurology. 2001;57(12):2278-2282. (Pubitemid 34019205)
14. Raschetti R, Spila-Alegiani S, Vanacore N, Ancona C, Meco G. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs. Acta Neurol Scand. 1998;97(1):20-26. (Pubitemid 28057383)
15. Ishihara LS, Cheesbrough A, Brayne C, Schrag A. Estimated life expectancy of Parkinson's patients compared with the UK population. J Neurol Neurosurg Psychiatry. 2007;78(12):1304-1309. (Pubitemid 350221407)
16. Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure tomaneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol. 2009;169(8):919-926.
17. Kamel F, Tanner C, Umbach D, et al. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol. 2007;165 (4):364-374.
18. Weisskopf MG, Weuve J, Nie H, et al. Association of cumulative lead exposure with Parkinson's disease. Environ Health Perspect. 2010;118(11):1609- 1613.
19. Willis AW, Evanoff BA, Lian M, et al. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am J Epidemiol. 2010;172(12):1357-1363.
20. US Department of Health and Human Services. Agency for Healthcare Related Research and Quality Web site. www.ahrq.gov. Accessed August 4, 2011.
21. Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143-151.
22. Centers for Medicare & Medicaid Services. Chronic Condition Data Warehouse Data Dictionaries Web site. http://www.ccwdata.org/data-dictionaries/ index.htm.
23. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-1251. (Pubitemid 24361532)
24. US Department of Agriculture Economic Research Service. US Department of Agriculture Web site. http://usda.gov/wps/portal/usda/usdahome.
25. US Census Bureau. United States Census Bureau Web site. http://www.census.gov/.
26. Schootman M, Jeffe DB, Lian M, Gillanders WE, Aft R. The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol. 2009; 169(5):554-561.
27. Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology. 2011;77(9):851-857.
28. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease: results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol. 2008;255(2):255-264.
29. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001; 56(1):49-56. (Pubitemid 32059651)
30. Sabbagh MN, Adler CH, Lahti TJ, et al. Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord. 2009;23(3):295-297.
31. Sakakibara R, Uchiyama T, Yamanishi T, Kishi M. Genitourinary dysfunction in Parkinson's disease. Mov Disord. 2010;25(1):2-12.
32. Pennington S, Snell K, Lee M, Walker R. The cause of death in idiopathic Parkinson's disease. Parkinsonism Relat Disord. 2010;16(7):434-437.
33. Centers for Medicare & Medicaid Services. Medicare Prescription Drug, Improvement, and Modernization Act. https://www.cms.gov/mmaupdate/downloads/ pl108-173summary.pdf. Published April 2004.